SAMHD1 was clearly detected in at least two cancer tissue types susceptible to being treated with antimetabolites—pancreatic adenocarcinoma and lung large cell carcinoma (Figure 7A,B). This evidence concerns the gene SAMHD1 and pancreatic adenocarcinoma.